Table 7.

The modified Rankin Scale scores assessed at discharge within 3 months or at 3 months after onset

Grade	0	1	2	3	4	5	Death
Edaravone (n = 125)	27	36	29	12	10	7	4	p = 0.0382*
Placebo (n = 125)	12	35	40	12	15	6	5

Grade: 0, no symptoms at all; 1, no significant disability despite symptoms; 2, slight disability; 3, moderate disability; 4, moderately severe disability; 5, severe disability. *Wilcoxon’s rank sum test.